Articles From: CYREN Technology Integrated into Byzoro Security Appliances to D-BOX Technologies Announces the Election of its Directors


MCLEAN, Va.
Sign-up for CYREN Technology Integrated into Byzoro Security Appliances investment picks
AvailaSoft expands CYREN WebSecurity's presence with its network of partners spanning 13 countries MCLEAN, Va.
Sign-up for CYREN WebSecurity Service to be Offered by AvailaSoft in APAC Region investment picks
Global colocation solutions provider CyrusOne (NASDAQ: CONE) is pleased to announce that Chief Technology Officer Kevin Timmons has been named as a finalist for the 2014 Tech Titans Corporate CTO award.
Sign-up for CyrusOne CTO Kevin Timmons Named 2014 Tech Titans Corporate CTO Award Finalist investment picks
CyrusOne Inc. (NASDAQ:CONE) will hold its second quarter 2014 results conference call at 12:00 PM Eastern Time (11:00 AM Central Time) on Wednesday, August 6, 2014.
Sign-up for CyrusOne Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Date investment picks
CyrusOne Inc. (NASDAQ:CONE) (“CyrusOne”) has closed a public offering of 15,985,000 shares of its common stock, which included 2,085,000 shares of common stock sold pursuant to the option granted to the underwriters by CyrusOne, which was exercised prior to the closing, at a price to the public of $23.25 per share.
Sign-up for CyrusOne Inc. Closes Public Offering of Common Stock investment picks
Global data center service provider CyrusOne Inc. (NASDAQ: CONE) announced today that it will present at the Bank of America Merrill Lynch 2014 Media, Communications and Entertainment Conference.
Sign-up for CyrusOne Inc. to Present at the Bank of America Merrill Lynch 2014 Media, Communications and Entertainment Conference investment picks
Global colocation provider CyrusOne (NASDAQ: CONE) President and CEO, Gary Wojtaszek , took home Saturday the honor of 2014 EY Entrepreneur of the Year™ for the Southwest Region in the technology category.
Sign-up for CyrusOne President and CEO Wins 2014 EY Entrepreneur of the Year in Southwest Region investment picks
Global data center service provider CyrusOne Inc. (NASDAQ:CONE), which specializes in providing highly reliable enterprise-class, carrier-neutral data center properties to the Fortune 1000, today announced second quarter 2014 earnings.
Sign-up for CyrusOne Reports Second Quarter 2014 Earnings investment picks
Global colocation solutions provider CyrusOne (NASDAQ: CONE) is pleased to announce that it plans to house the infrastructure and 911-dispatch center for Carrollton, Coppell, Farmers Branch, and Addison, Texas.
Sign-up for CyrusOne to House First-Ever Colocated 911-Dispatch Center investment picks
CYS Investments, Inc. (NYSE: CYS) (the "Company") today announced that it will host a conference call at 9:00 AM Eastern Time on Tuesday, July 22, 2014, to discuss its financial results for the quarter ended June 30, 2014.
Sign-up for CYS Investments, Inc. Announces Conference Call to Discuss Second Quarter 2014 Results investment picks
CYS Investments, Inc. (NYSE: CYS) (“CYS”, "we", "our", or the “Company”) today announced financial results for the quarter ended June 30, 2014.
Sign-up for CYS Investments, Inc. Announces Second Quarter 2014 Financial Results investment picks
The Board of Directors of CYS Investments, Inc. (NYSE: CYS) (the “Company”) today declared a quarterly dividend of $0.30 per share of common stock for the third quarter of 2014.
Sign-up for CYS Investments, Inc. Board of Directors Declares Third Quarter 2014 Common Stock Dividend of $0.30 Per Share, and Preferred Stock Dividends investment picks
CYS Investments, Inc. (NYSE: CYS) ("CYS" or the "Company") today announced that Kevin E.
Sign-up for CYS Investments, Inc. to Present at Barclays Global Financial Services Conference investment picks
CYS Investments, Inc. (NYSE: CYS) ("CYS" or the "Company") today announced that Kevin E.
Sign-up for CYS Investments, Inc. to Present at JMP Financial Services and Real Estate Conference investment picks
GAITHERSBURG, Md., Aug.
Sign-up for Cytomedix to Report Second Quarter 2014 Financial Results on Thursday, August 14, 2014 investment picks
Cytori Therapeutics (NASDAQ: CYTX) today announced that Mr.
Sign-up for Cytori Appoints a New Vice President of Finance and Chief Financial Officer investment picks
Cytori Therapeutics (NASDAQ: CYTX) today announced that six month outcomes from a 12 patient independent investigator-initiated study using Cytori Cell Therapy to treat scleroderma have been published in the Annals of Rheumatic Disease .
Sign-up for Cytori Cell Therapy Reduces Hand Disability and Pain in Scleroderma Patients investment picks
Cytori Therapeutics (NASDAQ: CYTX) has consolidated its EU operations to a new European office combined with a manufacturing facility in Deeside, Wales, UK.
Sign-up for Cytori Consolidates European Operations to Newly Opened Welsh Manufacturing Facility investment picks
Cytori Therapeutics (NASDAQ: CYTX) has placed enrollment in the ATHENA and ATHENA II trials on clinical hold and therefore anticipates that it will not be possible to complete enrollment of the ATHENA I trial prior to the end of 2014 as previously anticipated.
Sign-up for Cytori Provides Update on ATHENA Trial Status investment picks
Cytori Therapeutics (NASDAQ: CYTX) has received preliminary written notice of intent to exercise ‘Option 1’ of the Company’s contract with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services.
Sign-up for Cytori Receives Notice of Intent to Exercise First Contract Option from BARDA investment picks
Cytori Therapeutics (NASDAQ: CYTX) today reports its second quarter 2014 financial results and provides updates on clinical development and commercialization activities.
Sign-up for Cytori Reports Second Quarter 2014 Business and Financial Results investment picks
The Cardiovascular Cell Therapy Research Network (CCTRN), has selected Cytori (NASDAQ: CYTX) Therapeutics, Inc. to supply adipose-derived regenerative cells (ADRCs™) for a clinical trial aimed at evaluating the safety and feasibility of treating patients with Left Ventricular Assist Devices (LVADs). The CCTRN is supported by grants from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH). This trial, named CELLVAD-ADRC, will explore outcomes following administration of a regenerative cell preparation from adipose tissue into the patient’s heart muscle 60 to 90 days after placement of an LVAD.
Sign-up for Cytori Technology Selected for NHLBI Funded Trial in LVAD Patients investment picks
Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Monday, August 11, 2014 at 5:00 PM Eastern Time.
Sign-up for Cytori to Webcast Second Quarter Financial Results on August 11 investment picks
BENICIA, Calif.
Sign-up for CytoSport® To Be Acquired By Hormel Foods Corporation investment picks
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that it was added to the Russell 3000 ® and Russell 2000 ® Indexes when the Russell Investment Group reconstituted its family of U.S. indexes after the stock market close on June 27, 2014.
Sign-up for CytRx Added to Russell 3000® and Russell 2000® Indexes investment picks
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus ifosfamide/mesna as a first-line treatment in subjects with various sarcomas.
Sign-up for CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Ifosfamide/Mesna as First-Line Treatment in Patients with Advanced Sarcomas investment picks
CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended June 30, 2014, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs.
Sign-up for CytRx Reports 2014 Second Quarter Financial Results investment picks
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that President and CEO Steven A.
Sign-up for CytRx to Present at Upcoming Investor Conferences in New York City and Las Vegas investment picks
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare & Technology Conference.
Sign-up for CytRx Updates Presentation Time at Aegis 2014 Healthcare & Technology Conference investment picks
2014/8/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0962924001&sourceType=1 http://media3.marketwire.com/logos/20120919-D-BOX200.jpg LONGUEUIL, QUEBEC --
Sign-up for D-BOX Technologies Announces the Election of its Directors investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: CYREN Technology Integrated into Byzoro Security Appliances to D-BOX Technologies Announces the Election of its Directors
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices